Invivyd, Inc. (IVVD)
1.74
-0.06
(-3.33%)
USD |
NASDAQ |
Mar 13, 16:00
1.77
+0.03
(+1.72%)
After-Hours: 20:00
Invivyd EPS Diluted (Quarterly) : -0.0393 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0054 |
| MannKind Corp. | -0.0519 |
| Relmada Therapeutics, Inc. | -0.304 |
| Viemed Healthcare, Inc. | 0.1483 |
| Arcellx, Inc. | -1.003 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.07M |
| Revenue (Quarterly) | 17.21M |
| Total Expenses (Quarterly) | 28.28M |
| Enterprise Value | 181.44M |
| Gross Profit Margin (Quarterly) | 90.85% |
| Profit Margin (Quarterly) | -64.33% |
| Earnings Yield | -20.63% |
| Normalized Earnings Yield | -20.62 |